BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Krysiak R, Boldys A, Okopien B. Autoimmune Polyglandular Syndrome Type 2 Induced by Treatment With Interferon Alpha. The American Journal of the Medical Sciences 2011;341:504-7. [DOI: 10.1097/maj.0b013e31820ff7af] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Edvardsen K, Bjånesøy T, Hellesen A, Breivik L, Bakke M, Husebye ES, Bratland E. Peripheral Blood Cells from Patients with Autoimmune Addison's Disease Poorly Respond to Interferons In Vitro, Despite Elevated Serum Levels of Interferon-Inducible Chemokines. J Interferon Cytokine Res 2015;35:759-70. [PMID: 25978633 DOI: 10.1089/jir.2014.0171] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
2 Hellesen A, Edvardsen K, Breivik L, Husebye ES, Bratland E. The effect of types I and III interferons on adrenocortical cells and its possible implications for autoimmune Addison's disease. Clin Exp Immunol 2014;176:351-62. [PMID: 24666275 DOI: 10.1111/cei.12291] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
3 Masclee G, Aronson JK. Drugs that act on the immune system. A worldwide yearly survey of new data in adverse drug reactions and interactions 2014. [DOI: 10.1016/b978-0-444-62635-6.00037-1] [Reference Citation Analysis]
4 Vialettes B, Dubois-leonardon N. Les syndromes polyendocriniens autoimmuns de type 2 (APS-2). Bulletin de l'Académie Nationale de Médecine 2013;197:31-41. [DOI: 10.1016/s0001-4079(19)31624-3] [Reference Citation Analysis]
5 . Current world literature. Curr Opin Endocrinol Diabetes Obes 2012;19:233-47. [PMID: 22531108 DOI: 10.1097/MED.0b013e3283542fb3] [Reference Citation Analysis]